Literature DB >> 3882850

Demonstration of specific IgA in human feces after immunization with live Ty21a Salmonella typhi vaccine.

V Cancellieri, G M Fara.   

Abstract

An enzyme-linked immunosorbent assay was applied to evaluate the appearance of specific IgA in fecal eluates of 11 normal subjects given oral live Salmonella typhi Ty21a vaccine. All subjects after immunization showed a detectable rise in levels of specific IgA to both lipopolysaccharide and flagellar antigens of S. typhi.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3882850     DOI： 10.1093/infdis/151.3.482

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  9 in total

1.  Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.

Authors:  D Externest; B Meckelein; M A Schmidt; A Frey
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading.

Authors:  A Ferguson; K A Humphreys; N M Croft
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

3.  Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.

Authors:  S J Cryz; E Fürer; L S Baron; K F Noon; F A Rubin; D J Kopecko
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

4.  Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.

Authors:  J F Viret; D Favre; B Wegmüller; C Herzog; J U Que; S J Cryz; A B Lang
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium.

Authors:  P Michetti; M J Mahan; J M Slauch; J J Mekalanos; M R Neutra
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Human coproantibody secretory immunoglobulin A response to Yersinia species.

Authors:  K M Fletcher; C M Morris; M A Noble
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

7.  Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines.

Authors:  R D'Amelio; A Tagliabue; L Nencioni; A Di Addario; L Villa; M Manganaro; D Boraschi; S Le Moli; R Nisini; P M Matricardi
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

Review 8.  Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward.

Authors:  Marcelo B Sztein; Rosangela Salerno-Goncalves; Monica A McArthur
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

9.  Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial.

Authors:  Juan Manuel Carreño; Christian Perez-Shibayama; Cristina Gil-Cruz; Constantino Lopez-Macias; Pietro Vernazza; Burkhard Ludewig; Werner C Albrich
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.